HonorHealth announced the creation of its new international Center for Translational Science. Sanofi said it will repurchase $5.2 billion of stock and grow profits faster this year as the drugmaker ...
Biosciences receives US FDA orphan drug designation for MB-105 to treat relapsed/refractory CD5-positive T-cell lymphoma: Houston Thursday, January 30, 2025, 17:00 Hrs [IST] ...
Saudi Arabia's energy minister and several of his OPEC+ counterparts held talks following Trump’s call to lower oil prices, ...
By Daniella Parra March Biosciences was granted an orphan drug designation from the FDA to MB-105, its CD5-targeted CAR-T ...
MB-105, a first-in-class CD5-targeted CAR T-cell therapy, received FDA orphan drug designation for relapsed/refractory T-cell ...
A staff shortage at a southern Manitoba care home has led to beds being empty even as people are in desperate need of a ...
Company prepares to advance to Phase 2 clinical trial in early 2025HOUSTON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- March Biosciences (March Bio), an ...
Amazon’s “Deals of the Day” are going to save you more than 50% off an AMD Ryzen 7 5700G CPU and over 40% on the Logitech ...
Peavey Mart to shut down all 90+ stores across Canada, including its flagship in Red Deer, due to financial challenges and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback